FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

23182011000001101: Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 16-Oct 2013. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
75573701000001111 Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
75573801000001119 Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Is a Product containing precisely rizatriptan (as rizatriptan benzoate) 5 milligram/1 each conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has active ingredient Rizatriptan benzoate false Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has manufactured dose form Conventional release oral tablet true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has specific active ingredient Rizatriptan benzoate true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Has basis of strength substance Rizatriptan true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) 6 tablet Has AMP True Rizatriptan 5mg tablets (Alliance Healthcare (Distribution) Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start